[go: up one dir, main page]

DE3575671D1 - Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis. - Google Patents

Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.

Info

Publication number
DE3575671D1
DE3575671D1 DE8585400564T DE3575671T DE3575671D1 DE 3575671 D1 DE3575671 D1 DE 3575671D1 DE 8585400564 T DE8585400564 T DE 8585400564T DE 3575671 T DE3575671 T DE 3575671T DE 3575671 D1 DE3575671 D1 DE 3575671D1
Authority
DE
Germany
Prior art keywords
amoebiasis
production
saccharomyces yeast
medicine against
yeasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585400564T
Other languages
English (en)
Inventor
Philippe Gayral
Bernard Hublot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES BIOCODEX MONTROUGE FR
Laboratoires Biocodex SA
Original Assignee
LABORATOIRES BIOCODEX MONTROUGE FR
Laboratoires Biocodex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRES BIOCODEX MONTROUGE FR, Laboratoires Biocodex SA filed Critical LABORATOIRES BIOCODEX MONTROUGE FR
Application granted granted Critical
Publication of DE3575671D1 publication Critical patent/DE3575671D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585400564T 1985-03-22 1985-03-22 Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis. Expired - Lifetime DE3575671D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP85400564A EP0195870B1 (de) 1985-03-22 1985-03-22 Verwendung von Saccharomyces-Hefen für die Herstellung eines Arzneimittels gegen Amöbiasis

Publications (1)

Publication Number Publication Date
DE3575671D1 true DE3575671D1 (de) 1990-03-08

Family

ID=8194509

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585400564T Expired - Lifetime DE3575671D1 (de) 1985-03-22 1985-03-22 Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.

Country Status (4)

Country Link
US (1) US4643897A (de)
EP (1) EP0195870B1 (de)
AT (1) ATE49884T1 (de)
DE (1) DE3575671D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
FR2711528B1 (fr) * 1993-10-25 1996-02-09 Biocodex Lab Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose.
DE4336888A1 (de) * 1993-10-28 1995-05-04 Thiemann Arzneimittel Gmbh Produkt, erhältlich aus Hefezellen von Saccharomyces boulardii und dessen Verwendung
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
BRPI0415388A (pt) * 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
WO2006022616A1 (en) * 2004-07-21 2006-03-02 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
ATE382677T1 (de) * 2005-02-18 2008-01-15 Gnosis Spa Verfahren zur herstellung von hefe-mikrokapseln
EP2040554A4 (de) * 2006-06-16 2010-05-26 Alltech Inc Verminderung der antibiotischen resistenz bei bakterien

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB930107A (en) * 1960-01-11 1963-07-03 Giuseppe Carlo Sigurta Therapeutic oral preparation of micro-organisms
FR1538957A (fr) * 1964-02-17 1968-09-13 Robert & Carriere Lab Perfectionnement à la culture des levures
BE652331A (de) * 1964-08-26 1965-02-26
FR2096887A1 (en) * 1970-07-10 1972-03-03 Griffon Henri Compsn contg dried yeast with high living cell count - - for dietetic use and treating intestinal disorders
FR2228470A1 (en) * 1973-05-09 1974-12-06 Degemont Marguerite Therapeutic compsn. contg. vitamin A, sulphur and live yeast - for treatment of disorders of the ear, nose and throat
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis

Also Published As

Publication number Publication date
EP0195870A1 (de) 1986-10-01
US4643897A (en) 1987-02-17
EP0195870B1 (de) 1990-01-31
ATE49884T1 (de) 1990-02-15

Similar Documents

Publication Publication Date Title
DiBlasio et al. Practitioners, religion and the use of forgiveness in the clinical setting.
ATE183087T1 (de) Verwendung von beta-hydroxy-beta- methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen
ATE158182T1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
EP1019072A4 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
DE3583849D1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
DE3888064D1 (de) Niederfrequenz-Elektrotherapiegerät.
ATE316792T1 (de) Stimulierung wirtseigener abwehrmechanismen gegen krebs
DE3575671D1 (de) Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
ATE79749T1 (de) Verwendung von einigen alkanoyl-l-carnitinen zur herstellung eines arzneimittels zur therapeutischen behandlung von ideopathischem oder induziertem parkinsonismus.
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
FR2624010B1 (fr) Compositions topiques heterogenes a base de microgranules de cafeine et/ou de ses derives, utiles comme amincissant et/ou dans le traitement de la cellulite, ainsi que leur preparation
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
RU93043630A (ru) Способ улучшения процессов памяти
CN1045887C (zh) 外伤膏的制备方法
Török et al. Long Term Post‐Treatment Follow‐up of Onychomycoses Treated with Ketoconazole/Langzeit‐Nachuntersuchungen mit Ketokonazol behandelten Onychomykosen
SU940774A1 (ru) Способ лечени пародонтоза у лиц пожилого и старческого возраста
CN1054287C (zh) 治疗肝炎的药物
魏稼 CHINESE EMPERORS AND ACUPUNCTURE
冯如珍 RELIEF OF OESOPHAGEAL CARCINOMATOUS OBSTRUCTION BY ACUPUNCTURE
Kawana et al. Treatment of recurrent genital herpes with PSK
石学敏 et al. 30 CASES OF “PULSELESS DISEASE” TREATED WITH ACUPUNCTURE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition